Renalytix PLC
LSE:RENX

Watchlist Manager
Renalytix PLC Logo
Renalytix PLC
LSE:RENX
Watchlist
Price: 7.25 GBX
Market Cap: 24m GBX
Have any thoughts about
Renalytix PLC?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Renalytix PLC

Revenue
3.4m USD
Cost of Revenue
-2.7m USD
Gross Profit
701k USD
Operating Expenses
-43.1m USD
Operating Income
-42.4m USD
Other Expenses
-3.9m USD
Net Income
-46.2m USD

Margins Comparison
Renalytix PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Renalytix PLC
LSE:RENX
24m GBP
21%
-1 245%
-1 358%
US
Veeva Systems Inc
NYSE:VEEV
36.7B USD
73%
23%
24%
US
Cerner Corp
LSE:0R00
31.3B USD
83%
13%
10%
AU
Pro Medicus Ltd
ASX:PME
23.9B AUD
100%
71%
50%
US
Doximity Inc
NYSE:DOCS
10B USD
90%
39%
34%
JP
M3 Inc
TSE:2413
995.8B JPY
58%
23%
16%
US
Inspire Medical Systems Inc
NYSE:INSP
5.7B USD
85%
2%
4%
US
Waystar Holding Corp
NASDAQ:WAY
5.3B USD
67%
12%
-6%
SE
Sectra AB
STO:SECT B
54.5B SEK
47%
-41%
25%
US
Vocera Communications Inc
F:V00
2.4B EUR
66%
0%
-4%
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16.9B CNY
43%
16%
11%
Country UK
Market Cap 24m GBP
Gross Margin
21%
Operating Margin
-1 245%
Net Margin
-1 358%
Country US
Market Cap 36.7B USD
Gross Margin
73%
Operating Margin
23%
Net Margin
24%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Operating Margin
13%
Net Margin
10%
Country AU
Market Cap 23.9B AUD
Gross Margin
100%
Operating Margin
71%
Net Margin
50%
Country US
Market Cap 10B USD
Gross Margin
90%
Operating Margin
39%
Net Margin
34%
Country JP
Market Cap 995.8B JPY
Gross Margin
58%
Operating Margin
23%
Net Margin
16%
Country US
Market Cap 5.7B USD
Gross Margin
85%
Operating Margin
2%
Net Margin
4%
Country US
Market Cap 5.3B USD
Gross Margin
67%
Operating Margin
12%
Net Margin
-6%
Country SE
Market Cap 54.5B SEK
Gross Margin
47%
Operating Margin
-41%
Net Margin
25%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Operating Margin
0%
Net Margin
-4%
Country CN
Market Cap 16.9B CNY
Gross Margin
43%
Operating Margin
16%
Net Margin
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Renalytix PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Renalytix PLC
LSE:RENX
24m GBP
-150%
-88%
-110%
-287%
US
Veeva Systems Inc
NYSE:VEEV
36.7B USD
13%
11%
12%
34%
US
Cerner Corp
LSE:0R00
31.3B USD
14%
8%
12%
10%
AU
Pro Medicus Ltd
ASX:PME
23.9B AUD
51%
36%
60%
91%
US
Doximity Inc
NYSE:DOCS
10B USD
19%
16%
21%
51%
JP
M3 Inc
TSE:2413
995.8B JPY
11%
8%
14%
14%
US
Inspire Medical Systems Inc
NYSE:INSP
5.7B USD
5%
5%
2%
5%
US
Waystar Holding Corp
NASDAQ:WAY
5.3B USD
-2%
-1%
2%
2%
SE
Sectra AB
STO:SECT B
54.5B SEK
29%
15%
-46%
-26%
US
Vocera Communications Inc
F:V00
2.4B EUR
-5%
-2%
0%
0%
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16.9B CNY
6%
4%
8%
7%
Country UK
Market Cap 24m GBP
ROE
-150%
ROA
-88%
ROCE
-110%
ROIC
-287%
Country US
Market Cap 36.7B USD
ROE
13%
ROA
11%
ROCE
12%
ROIC
34%
Country US
Market Cap 31.3B USD
ROE
14%
ROA
8%
ROCE
12%
ROIC
10%
Country AU
Market Cap 23.9B AUD
ROE
51%
ROA
36%
ROCE
60%
ROIC
91%
Country US
Market Cap 10B USD
ROE
19%
ROA
16%
ROCE
21%
ROIC
51%
Country JP
Market Cap 995.8B JPY
ROE
11%
ROA
8%
ROCE
14%
ROIC
14%
Country US
Market Cap 5.7B USD
ROE
5%
ROA
5%
ROCE
2%
ROIC
5%
Country US
Market Cap 5.3B USD
ROE
-2%
ROA
-1%
ROCE
2%
ROIC
2%
Country SE
Market Cap 54.5B SEK
ROE
29%
ROA
15%
ROCE
-46%
ROIC
-26%
Country US
Market Cap 2.4B EUR
ROE
-5%
ROA
-2%
ROCE
0%
ROIC
0%
Country CN
Market Cap 16.9B CNY
ROE
6%
ROA
4%
ROCE
8%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top